Y02A 50/30
Against vector-borne diseases
Official title: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Y02A50/30 (Against vector-borne diseases) appears on 23,251 US grants and 34,653 published applications in this corpus.
Search patents in Y02A- Granted patents
- 23,251
- Published applications
- 34,653
- Assignees
- 10,807
- Inventors
- 55,690
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 27 | 0 |
| 1977 | 38 | 0 |
| 1978 | 24 | 0 |
| 1979 | 29 | 0 |
| 1980 | 28 | 0 |
| 1981 | 41 | 0 |
| 1982 | 45 | 0 |
| 1983 | 37 | 0 |
| 1984 | 30 | 0 |
| 1985 | 41 | 0 |
| 1986 | 39 | 0 |
| 1987 | 51 | 0 |
| 1988 | 55 | 0 |
| 1989 | 65 | 0 |
| 1990 | 62 | 0 |
| 1991 | 66 | 0 |
| 1992 | 89 | 0 |
| 1993 | 121 | 0 |
| 1994 | 117 | 0 |
| 1995 | 131 | 0 |
| 1996 | 173 | 0 |
| 1997 | 296 | 0 |
| 1998 | 370 | 0 |
| 1999 | 361 | 0 |
| 2000 | 415 | 0 |
| 2001 | 423 | 114 |
| 2002 | 426 | 618 |
| 2003 | 420 | 913 |
| 2004 | 301 | 983 |
| 2005 | 319 | 901 |
| 2006 | 364 | 906 |
| 2007 | 352 | 882 |
| 2008 | 339 | 949 |
| 2009 | 447 | 1153 |
| 2010 | 539 | 1430 |
| 2011 | 560 | 1289 |
| 2012 | 706 | 1297 |
| 2013 | 785 | 1292 |
| 2014 | 1007 | 1509 |
| 2015 | 1081 | 1663 |
| 2016 | 1110 | 1754 |
| 2017 | 1219 | 1720 |
| 2018 | 1181 | 1727 |
| 2019 | 1322 | 1981 |
| 2020 | 1304 | 1921 |
| 2021 | 1265 | 1930 |
| 2022 | 1099 | 1871 |
| 2023 | 1105 | 2236 |
| 2024 | 1190 | 1823 |
| 2025 | 1094 | 1201 |
| 2026 | 542 | 590 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Polymeric forms of H-NOX proteins6 Oct 2026US 12,753,222 B2Omniox.Inc.
- Nucleic acids encoding humanized anti-PACAP antibodies29 Sep 2026US 12,747,291 B2H. Lundbeck A.S.
- Emulsion in water for preventing and treating yellow shoot of citrus fruit tree, preparation method and application method22 Sep 2026US 12,741,915 B2Zhuhai Runnong Science and Technology Co. Ltd
- Methods and compositions for detecting a target RNA22 Sep 2026US 12,742,196 B2The Regents of the University of California
- Disinfectant composition with rapid antiviral efficacy8 Sep 2026US 12,728,177 B2Kimberly-Clark Worldwide, Inc.
- Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition8 Oct 2026US 2026/0306472 A1Santen Pharmaceutical Co., Ltd.
- Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof1 Oct 2026US 2026/0294817 A1Impax Laboratories, LLC
- Ph20 polypeptide variants, formulations and uses thereof1 Oct 2026US 2026/0297551 A1Halozyme, Inc.
- Anthelmintic compositions and methods24 Sep 2026US 2026/0284141 A1University of Massachusetts
- Compositions and methods for the treatment of immunodeficiency24 Sep 2026US 2026/0285950 A1Adma Biomanufacturing, LLC
Most cited
By later US patents
- Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site1,449US 7,718,180 B22010
- Immunometric assays using monoclonal antibodies1,218US 4,376,110 AHybritech Incorporated · 1983
- Liposomes with enhanced circulation time1,198US 5,013,556 ALiposome Technology, Inc. · 1991
- Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics940US 8,008,449 B2Medarex, Inc. · 2011
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001